Performance prediction of gamma electron vertex imaging (GEVI) system for interfractional range shift detection in spot scanning proton therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sung Hun | - |
dc.contributor.author | Jeong, Jong Hwi | - |
dc.contributor.author | Ku, Youngmo | - |
dc.contributor.author | Jung, Jaerin | - |
dc.contributor.author | Kim, Chan Hyeong | - |
dc.date.accessioned | 2022-07-19T05:04:52Z | - |
dc.date.available | 2022-07-19T05:04:52Z | - |
dc.date.created | 2022-01-26 | - |
dc.date.issued | 2022-06 | - |
dc.identifier.issn | 1738-5733 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/170166 | - |
dc.description.abstract | The maximum dose delivery at the end of the beam range provides the main advantage of using proton therapy. The range of the proton beam, however, is subject to uncertainties, which limit the clinical benefits of proton therapy and, therefore, accurate in vivo verification of the beam range is desirable. For the beam range verification in spot scanning proton therapy, a prompt gamma detection system, called as gamma electron vertex imaging (GEVI) system, is under development and, in the present study, the performance of the GEVI system in spot scanning proton therapy was predicted with Geant4 Monte Carlo simulations in terms of shift detection sensitivity, accuracy and precision. The simulation results indicated that the GEVI system can detect the interfractional range shifts down to 1 mm shift for the cases considered in the present study. The results also showed that both the evaluated accuracy and precision were less than 1–2 mm, except for the scenarios where we consider all spots in the energy layer for a local shifting. It was very encouraging results that the accuracy and precision satisfied the smallest distal safety margin of the investigated beam energy (i.e., 4.88 mm for 134.9 MeV). | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Nuclear Society | - |
dc.title | Performance prediction of gamma electron vertex imaging (GEVI) system for interfractional range shift detection in spot scanning proton therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chan Hyeong | - |
dc.identifier.doi | 10.1016/j.net.2021.12.027 | - |
dc.identifier.scopusid | 2-s2.0-85122156559 | - |
dc.identifier.wosid | 000808039000004 | - |
dc.identifier.bibliographicCitation | Nuclear Engineering and Technology, v.54, no.6, pp.1 - 8 | - |
dc.relation.isPartOf | Nuclear Engineering and Technology | - |
dc.citation.title | Nuclear Engineering and Technology | - |
dc.citation.volume | 54 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 8 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002841720 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Nuclear Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Nuclear Science & Technology | - |
dc.subject.keywordPlus | SLIT-CAMERA | - |
dc.subject.keywordPlus | BEAM | - |
dc.subject.keywordPlus | VERIFICATION | - |
dc.subject.keywordAuthor | Beam range verification | - |
dc.subject.keywordAuthor | Gamma electron vertex imaging | - |
dc.subject.keywordAuthor | Prompt gamma | - |
dc.subject.keywordAuthor | Proton therapy | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1738573321006975?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.